Newsroom

CHICAGO--(BUSINESS WIRE)--Morningstar (Nasdaq: MORN) today announced that its Morningstar Wealth division is working with Apollo, Franklin Templeton and J.P. Morgan Asset Management to launch a suite of public/private model portfolios that give financial advisors a single, research-driven way to access private markets. Objective Portfolio Construction Meets Institutional Capabilities Morningstar Public/Private Select Series will bring together: Morningstar Wealth’s asset allocation, manager res...

TORONTO--(BUSINESS WIRE)--Poplin, the leading coast-to-coast laundry service platform in the U.S., today launched its services in Toronto. Local residents are now offered the same seamless, affordable laundry pickup and delivery experience that millions already rely on, powered by a trusted network of local, independent Laundry Pros. With laundry consistently recognized as one of the most time-consuming and dreaded household chores, Poplin’s arrival in Toronto gives consumers valuable time back...

DUBLIN & VANCOUVER, British Columbia--(BUSINESS WIRE)--Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies...

SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI (NASDAQ: PDYN), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, advanced avionics, precision-manufactured components, UAVs, and advanced aerospace engineering services, today announced it has been awarded a pair of contracts to research, develop, and operationally validate SwarmOS and Gremlin-X with U.S. Army warfighters, competitively selected under the Army’s Disruptive Applic...

AUSTIN, Texas--(BUSINESS WIRE)--SolarWinds, a leading provider of simple, powerful, secure observability and IT management software, today announced the appointment of Justin Henkel as its Chief Information Security Officer. Henkel brings more than two decades of experience spanning military service and the private sector. He joins SolarWinds after nearly five years at OneTrust, where he began as Head of the CISO Center of Excellence and advanced to Deputy CISO, building a portfolio centered on...

WASHINGTON--(BUSINESS WIRE)--HighGround today announced $6.5 million in seed funding to bring institutional-grade intelligence to the defense and aerospace investment market. The round was led by Next Frontier Capital, with participation from Tandem Ventures, Fulcrum Capital, and Context Ventures. Defense has become one of the most contested and capital-intensive markets in private equity and venture. The investors allocating into the sector, and the companies competing inside it, still make bi...

NEW YORK & SEATTLE--(BUSINESS WIRE)--KKR, a leading global investment firm, and Altavair, a leader in commercial aviation leasing and financing, today announced that KKR is making a $1.4 billion equity commitment to continue expanding its global portfolio of leased commercial aircraft in partnership with Altavair. The latest commitment builds on two prior aircraft leasing portfolios created in partnership with Altavair. The investment will primarily come from KKR’s Infrastructure and Asset-Base...

HOUSTON--(BUSINESS WIRE)--Uber, Nuro, and Lucid announce plans to bring robotaxi service to Houston in 2027...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE American: VENU), owner, operator, and developer of premium live entertainment destinations, today announced that Regent Bank has secured the naming rights to the Company’s highly-anticipated amphitheater located in Broken Arrow, Oklahoma. Formerly known as Sunset Amphitheater at Broken Arrow, Regent Bank Amphitheater is unlike anything built in the region. VENU® and Regent Bank’s multi-million-dol...

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, LLC, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), announced the first patient was dosed in the global pivotal Phase 3 INTREPID study evaluating sapablursen for the treatment of polycythemia vera (PV). Sapablursen is an investigational drug that has the potential to offer a once-monthly treatment option for patients with PV, a rare and potentially life-threatening hemato...